Article Cited by others

ORIGINAL ARTICLE

Clinical activity of abiraterone plus prednisone in docetaxel-naοve and docetaxel-resistant Chinese patients with metastatic castration-resistant prostate cancer

Lin Guo-Wen, Li Gao-Xiang, Dai Bo, Ye Ding-Wei, Kong Yun-Yi, Wang Yue, Shen Yi-Jun

Year : 2019| Volume: 21| Issue : 2 | Page no: 131-136

   This article has been cited by
 
1 Clinical outcomes of abiraterone acetate and predictors of its treatment duration in metastatic castration-resistant prostate cancer: Real-world experience in the Southeast Asian cohort
Jasmine Lim,Akara Amantakul,Nisha Shariff,Bannakij Lojanapiwat,Adlinda Alip,Teng Aik Ong,Shankaran Thevarajah,Firdaus Ahmayuddin,Adeline Mathew,Supon Sriplakich,Jaraspong Vuthiwong,Flora Li Tze Chong,Marniza Saad
Cancer Medicine. 2020;
[Pubmed]  [Google Scholar] [DOI]
2 Separate Chinese lines for prostate cancer?
FinnEdler von Eyben
Asian Journal of Andrology. 2018; 0(0): 0
[Pubmed]  [Google Scholar] [DOI]

 

Read this article